BioSpace News Archive

Pharm Country

HARMONY BIOSCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Harmony Biosciences Holdings, Inc. today announced that President and CEO, John C. Jacobs will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 4:30 p.m. PT/ 7:30 p.m. ET.

December 22, 2022
·
1 min read
Policy

Aptorum Group Limited Announces Results of 2022 Annual General Meeting of Shareholders

Regulatory News: Aptorum Group Limited announced the results of its 2022 annual general meeting of shareholders, which was held on December 21, 2022, in London.

December 22, 2022
·
5 min read
Business

PAVmed Partners with Novosound on Ultrasound Imaging Technology

PAVmed Inc. today announced that it has entered into a license option and joint research and development agreement with Novosound Ltd.

December 22, 2022
·
6 min read
Genetown

PureTech Provides End of Year Report on Key Progress

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, reported on the key progress made across its Wholly Owned Programs1 and Founded Entities2 in 2022.

December 22, 2022
·
19 min read
Pharm Country

New STIC trial data shows longer overall survival for therapy selection based on CELLSEARCH® CTC count in patients with metastatic breast cancer

Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced the promising long-term results of the STIC trial, on OS in patients with ER+/HER2- MBC.

December 22, 2022
·
5 min read
Business

Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer

Merck and Kelun-Biotech today announced that the companies have entered into an exclusive license and collaboration agreement to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer.

December 22, 2022
·
6 min read
Business

BioCardia Letter to Shareholders

BioCardia, Inc. (Nasdaq: BCDA), a clinical-stage developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases issued the following letter to shareholders.

December 22, 2022
·
16 min read
Pharm Country

Merck to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, is scheduled to participate in a fireside chat at the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, Jan. 5, 2023, at 8:55 a.m. ET.

December 22, 2022
·
3 min read
Pharm Country

Elite Pharmaceuticals Files ANDA with US FDA to Market Dopamine Agonist

Elite Pharmaceuticals, Inc. today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) for an undisclosed extended-release generic drug product in a class of medications called dopamine agonists.

December 22, 2022
·
2 min read
Lone Star Bio

Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures

Orthofix Medical Inc. today announced results from a prospective, multicenter clinical study evaluating the safety and efficacy of the Trinity Elite ™ cellular bone allograft (CBA) in lumbar spinal fusion procedures.

December 22, 2022
·
6 min read